Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages

  Koval, Kathryn W ^a   Setji, Tracy L ^b   Reyes, Eric ^b   Brown, Ann J ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; ASIAN; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EUROPEAN AMERICAN; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ORAL CONTRACEPTION; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; UNITED STATES; ADOLESCENT; BLOOD; ETHNOLOGY; GLUCOSE TOLERANCE TEST; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; CHOLESTEROL, HDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; TRIGLYCERIDES; UP-REGULATION; YOUNG ADULT;

EID: 77956589589     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0074     Document Type: Article

References (16)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee 2010 Heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation 121:e46-e215
2. Bower JF, Deshaies Y, Pfeifer M, Tanenberg RJ, Barakat HA 2002 Ethnic differences in postprandial triglyceride response to a fatty meal and lipoprotein lipase in lean and obese African American and Caucasian women. Metabolism 51:211-217
3. Tyroler HA, Glueck CJ, Christensen B, Kwiterovich Jr PO 1980 Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence Study. Circulation 62:IV99-IV107
4. Frontini MG, Srinivasan SR, Xu JH, Tang R, Bond MG, Berenson G 2007 Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (the Bogalusa Heart Study). Am J Cardiol 100:64-68
5. LaRosa JC, Brown CD 2005 Cardiovascular risk factors in minorities. Am J Med 118:1314-1322
6. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
7. Glueck CJ, Morrison JA, Goldenberg N, Wang P 2009 Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population. Metabolism 58:714-721
8. Zawadzki J, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Oxford, England: Blackwell Scientific; 377-384
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:s2486-2497
10. Zeno SA, Kim-Dorner SJ, Deuster PA, Davis JL, Remaley AT, Poth M 2010 Cardiovascular fitness and risk factors of healthy African Americans and Caucasians. J Natl Med Assoc 102:28-35
11. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdóttir H, Gudlaugsdóttir G, Ingadóttir G, Crowley WF 2006 Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 91:4361-4368
12. Cui Y, Blumenthal R, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL 2001, Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161:1413-1419
13. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE 2005 Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294:326-333
14. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC 2005 Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 165:1395-1400
15. Gower BA, Ard JD, Hunter GR, Fernandez J, Ovalle F 2007 Elements of the metabolic syndrome: association with insulin sensitivity and effects of ethnicity. Metab Syndr Relat Disord 5:77-86
16. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM 2007 Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298:309-316